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Abstract
Nutrient deﬁciencies have been implicated in anti-social behaviour in schoolchildren; hence, correcting them may improve sociability.
We therefore tested the effects of vitamin, mineral and n-3 supplementation on behaviour in a 12-week double-blind randomised placebo-
controlled trial in typically developing UK adolescents aged 13–16 years (n 196). Changes in erythrocyte n-3 and 6 fatty acids and some
mineral and vitamin levels were measured and compared with behavioural changes, using Conners’ teacher ratings and school disciplinary
records. At baseline, the children’s PUFA (n-3 and n-6), vitamin and mineral levels were low, but they improved signiﬁcantly in the group
treated with n-3, vitamins and minerals (P= 0·0005). On the Conners disruptive behaviour scale, the group given the active supplements
improved, whereas the placebo group worsened (F= 5·555, d= 0·35; P= 0·02). The general level of disciplinary infringements was low, thus
making it difﬁcult to obtain improvements. However, throughout the school term school disciplinary infringements increased signiﬁcantly
(by 25 %; Bayes factor= 115) in both the treated and untreated groups. However, when the subjects were split into high and low baseline
infringements, the low subset increased their offences, whereas the high-misbehaviour subset appeared to improve after treatment. But it was
not possible to determine whether this was merely a statistical artifact. Thus, when assessed using the validated and standardised Conners
teacher tests (but less clearly when using school discipline records in a school where misbehaviour was infrequent), supplementary nutrition
might have a protective effect against worsening behaviour.
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The relationship between diet and behaviour is complex and
poorly understood. Childhood malnutrition has been associated
with behavioural problems such as in attention, aggression and
impaired socialisation(1). Individuals with micronutrient and n-3
PUFA deﬁciencies may be particularly prone to such anti-social
behaviour(2) and aggression(3,4).
EPA and DHA are particularly important for brain health. EPA
is converted into many important signalling eicosanoids, and
DHA is a major constituent of neuronal and glial cell membranes.
Thus, the early development of the brain is vulnerable to
deﬁciencies of these fatty acids in the diet(4,5). In addition, a high
n-6:n-3 ratio may lead to an overproduction of n-6 eicosanoids(6),
which can adversely affect neurotransmission(7). Many studies
use a single-nutrient intervention, an approach that has
methodological and generalisability limitations. A recent review
suggests that a multi-nutrient approach can ameliorate anti-social
behaviour as well as a range of psychiatric symptoms(8). From a
cognitive health point of view, the metabolic processes governing
neurotransmitter production and utilisation require cofactors for
enzyme action, which generally comprise vitamins and
minerals(9). It is reasonable to suggest that an appropriate nutrient
intervention for improvement of cognitive health and behaviour
would be one that contains a broad range of vitamins, minerals
and essential fatty acids (EFA)(10,11). Parletta et al.(12) provide
mechanistic insights for the role of nutrients in cognitive health.
Increasing n-3 PUFA and micronutrient intake may therefore be
an effective way to improve brain function and behaviour.
Supplementary multinutrient intervention has been shown to
signiﬁcantly reduce disciplinary transgressions by schoolchildren in
a working class environment(13) and by young prisoners(14–16).
However, studies in typically developing adolescent schoolchildren
are lacking. In 8- to 10-year-old schoolchildren, little inﬂuence of
supplementation was seen on cognitive outcomes(17), but a small
behavioural effect was detected, which the authors concluded
was equivocal. However, n-3 supplementation (in fruit juice) in
8- to 16-year-old community-dwelling Mauritanian children led to
reductions in parent-rated behaviour problems(18). Whether this
result would apply to UK children is not known.
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Many trials focus on children with neurodevelopmental
disorders – for example attention-deﬁcit hyperactivity disorder
(ADHD). Older studies have implicated poor diets in anti-social
behaviour(19–21) and more recently signiﬁcant behavioural
improvements have been reported after supplementation(22–26).
However, some studies(27,28) found no improvement in children
with ADHD after supplementing with DHA alone, whereas
supplementation with broad-spectrum vitamins and minerals
in adults with ADHD did improve symptoms(29). But EFA
supplementation produced no changes in aggression, hostility
and irritability in trials using normal volunteers(30,31). In studies
that utilised micronutrients (in the absence of EFA), Fe sup-
plementation led to improvements, v. placebo, in ADHD
measures in young children aged between 5 and 8 years(32) and
Mg supplementation with and without vitamin B6 in children
with ADHD, respectively, led to improvements in attention
and aggression(33) and reductions in hyperactivity(34).
Furthermore, multivitamin supplementation in young adults led
to improvements in serum vitamin levels and measures of
behaviour such as agreeability and composure(35). Thus,
there may be important potential for a multinutrient approach
in treatment of neurobehavioural conditions(8). However,
multivitamin supplementation in addition to PUFA provided no
additional beneﬁt over PUFA alone(25), but the authors suggest
that the multivitamin dose might have been insufﬁcient to
provide treatment efﬁcacy.
As regards adolescent schoolchildren, the evidence is
highly heterogeneous in terms of study design, population,
outcome measure, nutrient intervention and scientiﬁc rigour.
Nevertheless, the evidence for improved behaviour after
nutritional supplementation in correctional facilities is
consistent. Hence, the balance of evidence would suggest a
positive role for multiple vitamins, minerals and EFA in
both neuro-impaired and neurotypical individuals. Therefore, a
similar intervention may improve behavioural outcomes in
other contexts, such as in schools.
We therefore decided to study adolescents in an
underprivileged area in England. The UK Low Income Diet
and Nutrition Survey(36) showed that individuals in lower
socioeconomic groups are likely to have signiﬁcant
micronutrient deﬁciencies. The UK National Diet and Nutrition
Survey suggests that in particular n-3 PUFA intake from oily
ﬁsh may be well below recommendations(37). There is also
evidence to suggest that cognitive improvements can be gained
from supplements even in individuals enjoying adequate
nutritional status(35,38).
Here we describe a double-blind randomised placebo-
controlled nutritional intervention trial to compare
the behavioural effects of vitamin, mineral, DHA and EPA
supplements with placebo in typically developing 13- to
16-year-old adolescent schoolchildren in the UK. We used
multi-nutrient supplementation as a proxy for an improved
diet, which, although it cannot offer mechanistic insights, can
assess the efﬁcacy of treatment. Our intention was not to
ascertain the relative importance of individual nutrients, rather
to provide treatment with multiple nutrients at physiological
doses in a population that is likely to be experiencing
broad-spectrum low micronutrient intake.
Methods
This was a parallel-group, randomised, double-blind, placebo-
controlled study. The aim was to assess the impact of
micronutrient and EFA supplementation on behaviour in
adolescent schoolchildren aged between 14 and 15 years.
Participants
A large comprehensive secondary school (Robert Clack
School), which educates 11- to 18-year-old boys and girls,
hosted this study. The school, which provided great support, is
located in the East End of London borough of Barking and
Dagenham. A large proportion of adults in the surrounding area
are economically inactive and hold no formal educational
qualiﬁcations. Consequently, many children face adverse
environments and poor nutrition, which can manifest as
challenging behaviour at school.
Typically developing schoolchildren from years 9 and 10
(predominantly aged 14–15 years, with a minority aged 13 and
16 years) were invited to participate in the trial. Its purpose and
requirements were fully explained before recruitment took
place. Pupils (n 196) were recruited over four school terms and
randomised to either active treatment or placebo for a single
term (approximately 3 months). Exclusion criteria were major
medical disorders (including ADHD/ADD), prescribed
psychoactive medication, current consumption of multivitamin
and/or ﬁsh oil supplements, allergy to ﬁsh and eating ﬁsh
>2 times/week. Participants were recruited and allocated
according to the ﬂowchart in Fig. 1.
Ethics
The study was conducted according to the guidelines of the
Declaration of Helsinki, and all procedures involving human
subjects were approved by the South West Research Ethics
Committee (Ref: 10/H0206/13). Written informed consent was
obtained from all subjects’ parents. Children provided verbal
assent, before initial testing, which was witnessed and formally
recorded. Participants were able to leave the study at any time
without reason. The trial was registered at Current Controlled
Trials in the same month, immediately before recruitment
(http://www.controlled-trials.com) ISRCTN03817376.
Power and sample size
We computed power by performing the same statistical analysis
that we would apply to the real data, on 1000 simulated
data sets. If the average rate of offences is 0·05/subject per d
(corresponding to 3·85 offences over the 77 mean d of the study),
the power to detect an improvement of 28 % (corresponding to
αA= 0·25 in our statistical model) at a threshold corresponding to
0·05 signiﬁcance would be about 0·80. (We took the variance
parameter – measuring the variation among children in their
offence rates – to be 0·0040, but substantial changes in this
parameter were found to produce only minor changes in the
power.) If the mean offence rate were only 0·02, the power
would drop to 0·454; if the mean offence rate were raised to 0·10,
the power would go up to 0·97.
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Intervention
Active daily treatment was one tablet containing multivitamins/
minerals and two capsules containing n-3 PUFA (WellTeen Plus;
Vitabiotics Ltd). The potency of the active vitamin and mineral
supplementation is described in online Supplementary Table S1
and compared with UK reference nutrient intake(39) where
applicable. The active PUFA supplement contained EPA (165mg)
and DHA (116mg), and thus the children consumed 281mg/d
combined EPA plus DHA. The placebo tablets contained dical-
cium phosphate with potato starch and the placebo capsules
contained sunﬂower oil, which were colour-, odour- and ﬂavour-
matched with the active tablets and capsules. Active and placebo
allocation was carried out according to a randomisation schedule
provided by the manufacturer of the supplements and allocated to
participants on a per-cohort basis. Supplements were dispensed
from individually labelled compartment trays, which had minimal
risk of contamination. Trays remained locked at all times, other
than during the lunchtime supplementation period. Researchers,
participants and school staff were blind to treatment allocation.
Before commencing supplementation and at the end of the study,
participants were asked whether they thought they had received
active or placebo treatment. In addition, teachers who completed
the behaviour questionnaire were asked whether they thought the
participant had received active or placebo treatment.
During the 12-week intervention period, participants were
given supplements with a cup of water during the lunch break
during school days. Compliance was monitored by observing
swallowing, and it was recorded on a register. This greatly
reduced the risk of participants discarding or swapping pills.
At weekends and other planned absences, participants were
provided with an appropriate amount of supplements with
instructions to consume them on a daily basis. They conﬁrmed
compliance on a tick-box form.
Outcome measures
Baseline dietary intake. Participants were asked to keep a 7-d
food diary by detailing everything consumed in the week before
commencing the study. Completed diaries were analysed
for nutrient composition using Dietplan 6.5 (Forestﬁeld), and
baseline differences between treatment groups were calculated
to ascertain the level of matching of diet in participants between
groups.
Erythrocyte essential fatty acid and micronutrient analysis.
Venous blood samples were taken from the ﬁfty-three partici-
pants who consented to provide blood. A phlebotomist collected
10ml of blood into a labelled EDTA tube (Becton Dickinson).
Children expressed interest in
participating (n 408)
Declined to participate (n 212)
• Subsequently uninterested (n 104)
• Parental refusal (n 18)
• Already taking supplements (n 25)
• Medical condition (n 11)
• Fish allergy (n 5)
• Did not respond (n 12)
• Unable to swallow pills (n 37)
Randomised to participate in 
RCT (n 196)
Baseline
Allocated to, and received, active (n 98)
Discipline data (n 98)
Conners data (n 92)
• Unable to complete questionnaire (n 6)
Blood data (n 34)
Baseline
Allocated to, and received, placebo (n 98)
Discipline data (n 98)
Conners data (n 91)
• Unable to complete questionnaire (n 7)
Blood data (n 25)
Post intervention
Discipline data (n 98)
Conners data (n 91)
• Lost to follow-up (n 1)
Blood data (n 32)
• Lost to follow-up (n 2)
Post intervention
Discipline data (n 98)
Conners data (n 88)
• Lost to follow-up (n 3)
Blood data (n 22)
• Lost to follow-up (n 3)
Analysis
Discipline data (n 98)
Conners data (n 91)
Blood data (n 32)
Analysis
Discipline data (n 98)
Conners data (n 88)
Blood data (n 22)
Fig. 1. Flow of participants through the study. RCT, randomised controlled trial.
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Tubes were immediately transferred to a chilled transport box and
delivered to Oxford for overnight storage at 4°C in a blood fridge.
Samples were then spun at 4°C at 2000 rpm for 20min to separate
the various fractions. Plasma and erythrocyte fractions were
separated and stored in cryovials before long-term storage at
−80°C. The PUFA EPA, DHA, total n-3, total n-6, n-6:n-3 ratio
and n-3 +n-6 (n-3 index) were analysed in erythrocytes according
to the method of Bell et al.(40). Additional micronutrients analysed
in plasma were Fe, ferritin, folate, vitamin C and vitamin D. These
micronutrients were analysed at Medical Research Council Human
Nutrition Research (Cambridge) according to the following
methods. Fe was measured colourimetrically using the Siemens
Dimension Xpand; the assay uses Ferene® as chromophore. Total
Fe-binding capacity is measured by saturating all Fe-binding sites
with added ferric salt and then releasing it and measuring the
released Fe using the same reaction. Ferritin was measured using
the Siemens Dimension automated immunoassay, which uses a
CrO2 microparticle solid phase and β-galactosidase label. Folate
was measured on the Siemens Advia Centaur, using a competitive
immunoassay with a ﬂuorescence end point. Vitamin C (ascorbic
acid) was measured in plasma stabilised with metaphosphoric acid.
Ascorbic acid in the sample is converted to dehydroascorbic acid
by ascorbate oxidase; this is then coupled to o-phenylenediamine
to form quinoxaline, which can be quantiﬁed by ﬂuorescence.
25-Hydroxyvitamin D (25(OH)D) was measured using the Liaison
Analyser (Diasorin), which uses a direct non-extraction chemilu-
minescent immunoassay method. The antibody is immobilised on
magnetisable particles and the competing antigen is a 25(OH)D-
isoluminol conjugate. We had intended to analyse additional
nutrients from venous blood samples; however, as a result of
technical difﬁculties in processing the blood samples, this was
unfortunately not possible, and this anomaly is reﬂected in the
discussion.
Conners teacher assessment of behaviour. Teachers rated
pupil behaviour using the Conners Clinical Index Teacher Rating
Scale (a twenty-four-question test from the battery of Conners
Comprehensive Behaviour Rating Scales)(41), ﬁrst immediately
before capsule administration and a second time towards the end
of the ﬁnal week of intervention. As measures of child behaviour
and social and psychological functioning, Conners scales are
age-standardised and have been shown to be valid and reliable.
T-scores (mean 50 (SD 10)) were calculated, with higher scores
indicating increased severity of behavioural symptoms. These tests
have previously been used in n-3 fatty acid supplementation trials
in schools(42). Although the Conners’ test provides ﬁve subscales,
we expected the disruptive behaviour disorder subscale to show
the greatest changes, and thus our analysis focused on this score.
School discipline records. Negative behaviours resulting in
disciplinary action were logged in the school’s self-designed
databases on a daily basis (e.g. at the Pupil Referral Unit or
Learning Support Centre and additional databases). Databases
provided logs of, inter alia, dates, times and reason for referral –
for example, disruptive behaviour, aggression, tardiness and so on.
School records were reviewed for disciplinary incidents during the
treatment period. Historic records were obtained from the previous
school term to provide baseline discipline information. Number
(and rate) of reports over a period of time was the outcome
measure. Similar indicators of behaviour have been used in nutrient
supplementation trials in schools and prisons(15,16).
Statistical analysis
Other than for the discipline data analyses (see below), SPSS
version 19 for Mac (SPSS Inc.) was used. In all cases, two-tailed
signiﬁcance values are given and P≤ 0·05 was considered
statistically signiﬁcant.
Baseline measurements and allocation of treatment
guesses. Age, cohort, year group and treatment allocation
guesses are expressed as mean and standard deviations.
Comparisons were performed using the χ2 test. Baseline dietary
data, expressed as mean and standard deviations, were compared
using independent samples t tests.
Erythrocyte PUFA and micronutrient status. Within- and
between-group analyses of PUFA and micronutrient concentrations
were carried out on a per-protocol basis, excluding participants if
follow-up data were missing. Paired t tests were performed on
each subscale to evaluate the effect of intervention on the active or
placebo groups. Furthermore, a one-way ANCOVA was performed
to calculate post-intervention between-group differences while
controlling for baseline differences. The independent variable was
the group allocation, the dependent variable was post-treatment
PUFA concentrations and the covariate was baseline PUFA
concentrations.
Conners teacher assessment. Within- and between-group
analyses of Conners subscale T-scores were carried out on a
per-protocol basis, by excluding participants if follow-up data
were missing. Paired t tests were performed on each subscale to
evaluate the change in mean score within the active or placebo
group. A one-way ANCOVA was also performed to estimate the
effect of the treatment on this change, while controlling for
baseline differences. The independent variable was the group
allocation, the dependent variable was post-treatment score and
the covariate was baseline score. Differences between groups
in calculated change (post−pre) scores were also analysed by
two-sample (paired within individuals) t tests. The results for all
tests are reported for all ﬁve subscales, but the disruptive
behaviour subscale was our primary interest.
School discipline records – full analysis. All participants were
included in the analysis of school disciplinary records, on an
intent-to-treat (ITT) basis. We analysed the treatment effect on
disciplinary offences in the schoolchildren within a Bayesian
modelling framework. This means that the treatment effect is
posed as an unknown random quantity whose distribution is to
be inferred from the data. We made the standard simplifying
assumption that each individual’s offences form a Poisson
process, occurring at a constant rate within a period (baseline or
treatment), although the rate differs for different individuals,
and may change from the baseline to the treatment period.
364 J. D. Tammam et al.
http:/www.cambridge.org/core/terms. http://dx.doi.org/10.1017/S0007114515004390
Downloaded from http:/www.cambridge.org/core. The University of Hertfordshire, on 09 Nov 2016 at 15:04:26, subject to the Cambridge Core terms of use, available at
A detailed model description, along with estimation techniques,
can be found in the online Supplementary Material. The crucial
estimate of effect size, the proportional change in the offence rate
for those receiving the treatment, is therefore eαA. Negative values
of αA would correspond to our prediction that active treatment
would reduce an individual’s offence rate; positive values of αA
mean that active treatment increased the offence rate.
To test the signiﬁcance of the parameters, we make use of
Bayes factors, which are ‘summary measures that provide an
alternative to the p-value for the ranking of associations, or the
ﬂagging of associations as “signiﬁcant”’(43). Large Bayes factors
show strong evidence for the alternative hypothesis (similar to
small P values). Factors can be interpreted according to the values
shown in online Supplementary Table S3. The 95% highest pos-
terior density (HPD) interval is the shortest interval in parameter
space that contains 95% of the posterior probability.
One advantage of the Bayesian approach is that it provides a
natural resolution for the problem of data missing at random. In
some cases, discipline data were missing from some databases for
some students, as a result of inter-year group differences in school
databases. As these data may naturally be assumed to be missing
at random – that is, independent of any individual characteristics
of the individual students – such likelihood-based inference is
known to manage missing data well(44). The time at risk for each
pupil was adjusted to reﬂect missing data, as well as the fact that
all pupils were not in the same databases and therefore could not
be expected to have the same exposure. This approach also
naturally incorporates the baseline measures in estimating the
treatment effect. In doing so, it provides some correction for
random differences in underlying rates between the placebo and
treatment groups, a problem that turned out to be substantial in
this case (see below).
School discipline records – stratiﬁcation by number of
baseline offences. Inspired by the recent work of Long and
Benton(45), which seems to show a divergence of effect between
subjects selected on the basis of their scores at baseline – they
reported an improvement in the ‘high impulsivity’ at baseline
group, and their plots seem to show an equally strong deterioration
in the ‘low impulsivity’ group – we divided our subjects according
to their number of disciplinary events in the baseline period. The
‘high group’ included the twenty-ﬁve subjects with more than three
disciplinary events during the baseline period, and the ‘low group’
included the remaining 171 subjects.
We extended our Bayesian model to allow for different
treatment effects in these two groups.
A detailed model description of the adjusted model can be found
in the online Supplementary Material.
School discipline records – subgroup analysis with PUFA
measurements. We considered the possibility that the effect of
nutritional supplements might be proportional to individual
changes in blood levels of the nutrients. Comparing the individual
blood measurements with the behaviour changes could
then provide more power to detect the effect. Approximately one-
fourth of the participants consented to provide blood samples
from which erythrocyte PUFA and plasma levels of other
micronutrients were analysed. As before, detailed descriptions of
the hazard rates used are given in the online Supplementary
Material. The parameters α and αA have the same interpretations as
given in the section on the full analysis, but this model also
included the parameter β to measure the signiﬁcance of the
change in blood concentrations on behaviour. Again, negative
values of β would correspond to the predicted result that an
increase in the blood concentration would reduce a pupil’s
offence rate. Positive values of β would mean that an increase in
blood concentration raises a pupil’s offence rate.
Results
Baseline measures
At baseline, there were no signiﬁcant differences in sex, age,
year group or cohort between active and placebo groups
(Table 1). Unfortunately, however, randomisation did not
provide matched groups for baseline disciplinary infractions;
the disciplinary rates were 2·5 times greater in the placebo
group than in the active treatment group.
Number of days in treatment and compliance
The mean number of days in the study was 77·1 (SD 10·0) d for
the active group and 76·1 (SD 13·3) d for the placebo group –
that is, there was no signiﬁcant difference between the groups
(P= 0·56). The mean compliance rate was 88·4 (SD 10·9) % for
the active treatment and 88·5 (SD 8·8) % for the placebo group;
again this difference was not statistically signiﬁcant (P= 0·91).
Dietary intake
Food diaries were completed by most participants (n 117, active
n 66, placebo n 51). These revealed no signiﬁcant differences in
baseline nutrient intake between the groups (online Supple-
mentary Table S2). Mean number of days completed were
different between groups as a result of a small number of
Table 1. Baseline participant characteristics
(Numbers and percentages)
Active (n 98) Placebo (n 98)
Baseline n % n % χ2 P
Sex
Male 43 44 55 56 2·47 0·12
Female 55 56 43 44
Age (years)
13 8 8 9 10 1·16 0·76
14 53 54 50 50
15 37 38 38 38
16 0 0 1 2
Year/grade
9 12 12 14 14 0·04 0·83
10 86 88 84 86
Cohort
1 27 28 26 26 1·25 0·74
2 37 38 35 36
3 25 26 23 24
4 9 8 14 14
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individuals in the placebo group choosing to complete <7 d in
their diaries; however, this was not associated with differences
in mean daily nutrient intake.
Treatment guesses
At baseline, the proportion of participants who guessed cor-
rectly in either group was not statistically different (χ2= 1·93;
P= 0·17). However, after the treatment, the proportion of the
children who guessed correctly differed between groups
(χ2= 10·24; P= 0·001), with 56 and 70 % of students in the active
and placebo group, respectively, correctly guessing their
allocation. However, their teachers were unable to correctly
guess the treatment allocations (χ2= 1·31; P= 0·25).
Erythrocyte fatty acid and micronutrient analysis
Concentrations of erythrocyte membrane fatty acids expressed as
percentages can be seen in Table 2. The baseline EPA, DHA, total
n-3 and the n-3 index were very low, whereas the total n-6 and n-
6:n-3 ratios were very high. All these PUFA status measures
improved signiﬁcantly after 12 weeks of active treatment – that is,
EPA, DHA, total n-3 and the n-3 index increased, whereas total
n-6 and the n-6:n-3 ratio decreased (all P≤ 0·0005); this resulted
in large treatment effects, as seen by differences between active
and placebo groups post-intervention (all P≤ 0·0005). Similarly,
plasma concentrations of folate, vitamin C and vitamin D
increased signiﬁcantly (P≤ 0·001) as a result of supplementation
(Table 3). However, Fe and ferritin showed no signiﬁcant
changes. Other micronutrients of interest were unable to be
measured in the blood as a result of technical limitations.
Conners assessment
With regard to the trial registration, this was stated as a primary
outcome measure. The Conners’ Teacher’s mean scores are
shown in Table 4. The individual scores were normally dis-
tributed. We used a one-way ANCOVA to test for an effect of
the treatment on an individual’s change in score from the pre-
treatment to the post-treatment test. The disruptive behaviour
disorder subscale showed a signiﬁcant post-intervention
between-group difference (P= 0·02; Table 4). The treatment
group improved (decreased T-score) slightly, whereas the pla-
cebo group’s average T-score increased signiﬁcantly
(P= 0·005), meaning that their behaviour worsened. We did not
anticipate changes in any other subscales, and none of our
statistical tests show any signiﬁcant changes within or between
groups after the 12-week intervention.
An alternative approach is to perform t tests directly on the
changes in the Conners scores (post−pre). This showed
a signiﬁcant difference, between treatment groups, in the
disruptive behaviour subscale (P= 0·009; Fig. 2), with no other
signiﬁcant differences.
School discipline data – whole group analysis
With regard to the trial registration, this was stated as a primary
outcome measure. A small number of participants (n 7) stopped Ta
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taking supplements before the end of the trial period
(mean drop-out on treatment day 33 (SD 20)). These data were
still used in an ITT analysis as disciplinary and compliance data
were available for the period in which supplementation
was taken.
The results obtained in an ITT analysis using all pupil data
and ﬁtting the model using the hazard rate is described in the
online Supplementary Material (Table 5). Taking both groups
together, the pupils demonstrated a multiplicative increase in
the hazard rate of eα + αA, which corresponds to a signiﬁcant
increase in disciplinary offending by 25 %. Actually, the treated
group showed an additional increase in the hazard rate of eαA
(8·5 %), but this difference failed to reach statistical signiﬁcance
because of the high variability among pupils.
In other words , pupils in the placebo group increased their
offence rates by 25 (95% HPD 3; 48) % during the treatment
period, whereas pupils receiving the active treatment experienced
a 34 (95% HPD 2; 69) % increase in their offence rates. Although
the active group displayed a seemingly higher increase, there was
more uncertainty in the estimate, and thus the difference was
insigniﬁcant.
School discipline data – stratiﬁcation by the number of
baseline offences
After splitting the analysis into groups of high (>3 disciplinary
events during the baseline period) and low misbehaviour rates,
we found that the median estimate of the parameter βHA was
−0·674, implying a decrease of 51 (95% HPD 34; 62) % in mis-
behaviour rate among those in the high-misbehaviour group who
received the treatment, relative to those who received the placebo
(Table 6). However, also the median estimate of the parameter
βLA, 0·43, implied an increase of 53 (95% HPD 1; 137) % in
misbehaviour rate among those in the low-misbehaviour group
who received the treatment, relative to those who received the
placebo. We consider the result for the low-offending group
to have more statistical reliability, as explained further in the
‘Discussion’ section.
We repeated the analysis using thresholds of 1, 2, 3, 4 and 5
baseline offences and observed similar results. Lower thresholds,
by reducing the number of subjects in the low group, also
reduced the statistical signiﬁcance.
School discipline data – subgroup analysis with participants
who gave blood
It seems plausible to suppose that effects of the supplements
would be mediated by the amount by which blood levels change,
although this may be masked by variability in individual
responses to the supplements. If, for instance, a substantial
change in blood levels of EPA or other micronutrients improved
subjects’ behaviour, this may be seen in only some of the
treatment group. We looked for such an effect by ﬁtting various
models.
Our investigations conﬁrmed that such a model could in
principle improve the power to detect an effect that would be
obscured in a simple comparison of placebo and treatmentTa
b
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groups. Unfortunately, this potential improvement in power was
overwhelmed by the reduction in sample size, because of the
small number of subjects who agreed to give blood samples.
Therefore, these models were prone to overﬁtting, and turned out
to be highly sensitive to details of model choice and individual
outliers in the data.
Discussion
The main conclusions from this work are as follows: (1) that
teenagers from disadvantaged backgrounds tend to have very low
blood levels of DHA, EPA and other micronutrients; (2) these can
be effectively increased by taking appropriate supplements;
(3) that increasing these levels may reduce these students’
disruptive behaviour; and (4) this improvement may only translate
to a reduction in disciplinary offences in those with a high initial
level of infringements.
Blood ﬁndings
These children had extremely low levels of the n-3, DHA and EPA
coupled with relatively high levels of n-6 (although the latter were
still low by accepted standards). Although there are as yet no
ofﬁcially recommended levels of these fatty acids, the consensus
is that ideally EPA and DHA should constitute 8 % of total ery-
throcytes lipid composition(46). In these adolescents, they
amounted to only half of the ideal −4%. Although all nutrients are
important(47), n-3 are particularly so, especially when the brain is
experiencing rapid growth during puberty and is at its most
sensitive to insufﬁcient supply. EPA has a more functional role in
neural signalling in older subjects, whereas DHA has a more
structural neurodevelopmental role in nerve membranes. Stevens
et al.(48) found a correlation between improvements in conduct
and n-3 PUFA levels. In addition, increased DHA was found to be
associated with improvements in parent-rated behaviour(49).
We hoped therefore that improvements in EPA and/or DHA
levels in the blood would predict improvements in these
adolescents on our behavioural measures. However, this was not
seen, probably because of the small numbers of participants
opting to provide a blood sample. Neither did increased levels of
Fe, ferritin, folate, vitamin C or vitamin D predict improvements,
using the same models as for the n-3 PUFA. However, these
potential associations deserve further investigation. The use
of a less invasive technique such as ﬁnger prick may increase
volunteer numbers.
Nevertheless, signiﬁcant improvements in PUFA and
micronutrient status were seen in the participants who agreed to
provide blood. This ﬁnding conﬁrms the improvements in PUFA
status reported in many other studies – e.g. Hamazaki(30), Voigt
et al.(27) and Itomura et al.(23). Although we cannot be sure that this
improvement led to improved fatty acid proﬁles in the brain,
nevertheless Carver(50) showed that there is a signiﬁcant correlation
between erythrocyte and neuronal n-3 PUFA content in adults,
although this relationship failed to reach signiﬁcance in subjects
<18 years old. Importantly, the very low blood fatty acid (both n-3
and n-6) values at baseline of our participants suggest that these
children did indeed have a very poor diet. Their low intakes of n-3
PUFA (Table 2) are consistent with the very low intake ofTa
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foods containing long-chain n-3 PUFA in the typical British diet(37).
Their very low n-3 index would predict diminished protection
from CHD in adulthood(51). Although we achieved signiﬁcant
improvements post-treatment, the n-3 index did not reach the 8%,
which is associated with the greatest protection against CHD. This
may suggest that the duration of our supplementation was
insufﬁcient, and this could help explain our disappointing results
with respect to the children’s disciplinary offences. Future studies
might beneﬁt from addressing these points. Nonetheless, the results
of the fatty acid analysis provide normative values of erythrocyte
n-3 PUFA in typical underprivileged UK adolescents.
Limitations of the micronutrient analysis. We studied typi-
cally developing adolescent schoolchildren from a particularly
underprivileged demographic and environment. As such it was
expected and demonstrated that they would have a relatively
low intake of many micronutrients. Our intention was to
investigate all of these. However, technical issues in blood
storage and processing did not permit some of them. None-
theless, the micronutrients that we were able to analyse showed
that supplementation improved blood concentrations in almost
all cases. However, as with the PUFA, it is not possible to
ascertain whether this improvement led to improvements in
brain tissue levels.
Disruptive behaviour
Our results suggest that there may be a favourable effect of n-3
PUFA, vitamin and mineral supplementation on disruptive
behaviour in these typically developing adolescent schoolchildren,
as assessed by the Conners Teacher Rating Scale, but it was
probably small. The disruptive behaviour subscale scores
improved slightly in the treated group, whereas that of the placebo
group worsened considerably. The Conners questionnaire is a
standardised, valid and reliable assessment, and it appears to be
sensitive enough to detect modest treatment effects, even when
baseline scores were within a non-clinical range. The teachers
were unable to guess which pupils had been allocated active or
placebo, and thus their assessments were unlikely to have been
affected by their guesses; this strengthens our conﬁdence in the
reliability of the Conners data.
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Fig. 2. Conners subscales (changes in T-scores) post-treatment. ADHD, attention-deficit hyperactivity disorder.
Table 5. Treatment effect on school disciplinary incidents
(Mean values, standard deviations and 95% highest posterior density
interval (HPDI))
Mean SD 95% HPDI H0 Bayes factor
α 0·22 0·092 0·040; 0·40 α<0 115
αA 0·07 0·156 −0·23; 0·38 αA< 0 2·04
Table 6. Parameter estimates resulting from an MCMC chain of 100 000
iterations*
(Mean values, standard deviations and 95% highest posterior density
intervals (HPDI))
Mean SD 95% HPDI H0 Bayes factor
κH 3·326 0·136 3·058; 3·588
αH 0·354 0·092 0·170; 0·531 αH<0 >1000
αL 0·209 0·209 −0·208; 0·609 αL< 0 5·27
βHA −0·676 0·142 −0·957;−0·402 βHA> 0 >1000
βLA 0·428 0·216 0·012; 0·858 βLA< 0 42·44
λ 0·010 0·001 0·007; 0·012
* A large Bayes factor indicates evidence for the alternative hypothesis. The HPDI is
similar to a CI, but more straightforward to interpret. According to the model, the
probability is 95% that the true parameter lies within this interval. Thus, the
parameter βLA, measuring the change in offence rate among the baseline
low-offending group, is 95% likely to be between 0·012 and 0·858. In particular,
a two-tailed test at the 0·05 level would reject the hypothesis that this effect is 0.
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As expected, no effect was seen in the other Conners subscale
measurements. Kirby et al.(17) used a Strengths and Difﬁculties
Questionnaire to measure, inter alia, conduct problems and
prosocial behaviour. They found that treatment left the children’s
parent-rated prosocial behaviour scores unchanged, whereas in
the placebo group these worsened, yielding a signiﬁcant
advantage to the treated group. Similar between-group patterns
were seen by Itomura et al.(23) and Hamazaki et al.(21). Future
work could consider measuring other social outcome measures
such as callous and unemotional traits(52) or the Reactive and
Proactive Questionnaire(53).
Considering the P value for the Connors disruptive behaviour
subscale in isolation might reasonably be challenged, as it selects a
single subscale for testing, ignoring four others that showed no
signiﬁcant change. Considering all subscales together as multiple
tests of a single null hypothesis, a single P value of 0·02 (from the
ANCOVA) would not necessarily be statistically signiﬁcant, as a
Bonferroni correction would raise the P value to the range of
a trend (P=0·1), whereas two-sample t tests would still yield a
marginally signiﬁcant treatment effect on the Conners scale
(Bonferroni corrected from P=0·009 to P = 0·045). At the very
least, this suggests that the result be treated with some caution. On
the other hand, the disruptive behaviour subscale was the one that
was relevant for this study, and that we sought to measure. The
fact that four additional subscales come along as unavoidable
adjuncts of this tool, and could, in principle, themselves be
investigated for signiﬁcant treatment effects, does not detract from
the signiﬁcant treatment effect observed in the target measure.
Disciplinary data
When the school discipline records of all the volunteers were
analysed together, we could see no positive behavioural effect of
the supplementation. Over each school term the behaviour of
both groups worsened signiﬁcantly; unfortunately this termly
pattern is common in schools. Thus, all the pupils, taken together,
increased their offence rates by 25 (95% HPD 3; 48) %, and it
appears that receiving the active treatment had little effect on
offending as measured by these disciplinary records. Thus, our
disciplinary ﬁndings did not conﬁrm the ﬁndings of Schoenthaler
and Bier(13) in schoolchildren, or those of Gesch et al.(15), and
Zaalberg et al.(16), in prisoners; all these studies found reduced
offending behaviour after supplementation. However their
baseline levels of offending were higher, and different treatments
were used in each of them. Schoenthaler gave vitamins and
minerals alone, Gesch administered vitamins, minerals and PUFA
(predominantly n-6) and Zaalberg used vitamins, minerals and
PUFA (predominantly n-3). As a comparison, other than a
lower EFA content, our study used a similar formulation to
Zaalberg in that it contained doses of vitamins and minerals close
to reference levels.
A recent study(45) showed an improvement in laboratory-based
measures of aggression and impulsivity in young adults upon DHA
supplementation, particularly in those with higher baseline levels of
impulsivity. Indeed, some measures in that study seemed to show
deterioration among those receiving DHA supplementation if they
started with lower baseline levels of impulsivity. Our results from
analysis of the school discipline data (Table 6) show a similar
pattern, and they are suggestive of a large treatment effect v.
placebo only in children with high misbehaviour rates at baseline.
This pattern is what one might expect if the supplements reduced
the impulsivity and lack of executive control seen particularly in the
high offenders.
However, this conclusion should be viewed with caution.
The high-misbehaviour group consisted of only a small number
of individuals (twenty-ﬁve) with a very large number of
offences (as many as thirty-three at baseline). The estimated
effect size may thus be dominated by effects of regression to the
mean, which is highly dependent upon the choice of statistical
model. We have no strong theoretical basis for choosing
any particular model for this setting, and the small number
of subjects makes empirical estimation impossible. This
uncertainty is exacerbated by the difference in distribution
between the treatment and control groups, which was
unfortunately concentrated entirely in this high group. Despite
random allocation of active or placebo treatment, the overall
disciplinary rates in the two groups were very different during
the baseline period; the pupils in the active treatment group had
an average offence rate of only 0·017, whereas those in the
placebo group had an average rate of 0·042 – that is, it was
2·5 times greater than that of the active group. Using ten million
bootstrap samples, we found that the probability of achieving
this allocation at random was only 0·009 – that is, approximately
1 in 100; yet it happened in our case. Thus, most of the
proliﬁc offenders ended up in the placebo group, giving us less
information to estimate parameters associated with the active
treatment – hence the greater uncertainty around αA.
One virtue of the statistical procedures that we have used
here, which control for individual baseline observations, is that
our main parameter estimates should remain unbiased even in
the face of such an unbalanced allocation. The CI, however,
became broader than they would otherwise have been,
increasing our uncertainty. The unbalanced randomisation
also exacerbates model uncertainties. A simple randomisation
procedure was used in this study, and thus future studies might
beneﬁt from using stratiﬁed randomisation to ensure equal
distribution of proliﬁc offenders in each treatment group.
In addition, we had methodological problems with the
disciplinary records, which were not standardised or validated
measures of behaviour and consisted of four different registers
with different criteria. Despite their having being used in
similar trials in schools and prisons, and that they provide an
ecologically valid behavioural log, it may be that their
piecemeal application here as a measure of behavioural change
was inappropriate, leading to the contradictory results. Inspired
by results reported elsewhere(45), rather than only after looking
at our data, we decided to stratify the participants by their
baseline levels of misbehaviour, and found different outcomes
for those with high v. low levels. Thus, our failure to see any
advantage in the whole treated group may have been the result
of combining one group with low and another with high
misbehaviour rates at baseline, so that the treatment effects
opposed each other. It may also reﬂect difﬁcult-to-control
statistical ﬂuctuations in the small number of individuals
who were responsible for the largest number of offences,
exacerbated by the unfortunately unbalanced randomisation.
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Any analysis that includes the high-misbehaviour group is
subject to unpredictable effects of regression to the mean,
acting differentially between the treatment and control groups.
Indeed, one might argue that the main advantage of stratifying
by baseline behaviour was to remove this small but very
problematic subset from the model.
Our estimates of the treatment effect in the remaining
low-offence group (nearly 90 % of the original study popula-
tion) is more reliable statistically, as the treatment and placebo
groups within it had very similar distributions of offences, and
the estimates are not being driven by a small number of indi-
viduals with large numbers of offences. Proper estimation of the
treatment effect in the high-misbehaviour subpopulation would
require a larger sample size, and greater attention to matching
the treatment and placebo groups at baseline. The direction of
the effect in children in the low misbehaviour group was
opposite to that expected, although consistent with the recent
results of Long and Benton(45). We speculate that supple-
mentation in this group might have increased their general
alertness and energy, which may have made them unchar-
acteristically disrespectful, and that this may have been treated
as misbehaviour by the teachers. Therefore, supplementation
could be an effective therapeutic approach only in individuals
who have high rates of misbehaviour, but not so in those whose
behaviour is more typical.
Thus, our results suggest that active supplementation might
have had a moderating effect against an increase in aberrant
behaviour, when assessed using the Conners standardised tests,
but this is far less clear using the school disciplinary records.
Blinding
Interestingly, some participants were able to guess to which
treatment they had been allocated after the supplementation
period. Thus, a partial breaking of the blind might have
occurred. As the supplements were well matched for colour,
odour and ﬂavour, we suggest that these children had felt the
beneﬁt of their enhanced micronutrient levels (or otherwise, if
allocated placebo) and thus correctly identiﬁed their group. In
the study by Zaalberg et al.(16), the participants were also able
to guess correctly for similar reasons. We cannot know whether
this resulted in pupils purposely altering their behaviour, but it
would seem unlikely.
Conclusion
Previous studies in prisoners or children with dyspraxia or
ADHD have limited applicability to typically developing
children. We attempted to address this issue by recruiting
children with no formal diagnosis of any neurodevelopmental
condition. We found suggestive evidence that broad-spectrum
vitamin, mineral and n-3 supplementation might have a pro-
tective effect against anti-social behaviour, when assessed using
Conners scales. We also found some evidence that supple-
mentation may decrease misbehaviour among children whose
prior rates were high, yet may increase it in children whose
baseline rates were low. Thus, if aberrant behaviour is a
manifestation of non-optimal nutrient intake, these ﬁndings
warrant further investigation with larger numbers, increased
nutrient dose and stratifying offending rates.
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